Average Co-Inventor Count = 6.15
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Wyeth (8 from 1,309 patents)
2. Entasis Therapeutics, Inc. (3 from 11 patents)
3. Pfizer Corporation (2 from 4,455 patents)
4. Colucid Pharmaceuticals, Inc. (2 from 6 patents)
15 patents:
1. 10800778 - Beta-lactamase inhibitor compounds
2. 10376499 - Combination therapy for treatment of resistant bacterial infections
3. 10022381 - Triazine compounds as PI3 kinase and mTOR inhibitors
4. 9968593 - Combination therapy for treatment of resistant bacterial infections
5. 9174963 - Triazine compounds as PI3 kinase and MTOR inhibitors
6. 8859542 - Triazine compounds as PI3 kinase and mTOR inhibitors
7. 8835429 - Pyrimidine compounds, their use as mTOR kinase and Pl3 kinase inhibitors, and their syntheses
8. 8748421 - Triazine compounds as P13 kinase and MTOR inhibitors
9. 8575159 - Triazine compounds as PI3 kinase and mTOR inhibitors
10. 8445486 - Triazine compounds as PI3 kinase and mTOR inhibitors
11. 8217036 - Triazine compounds as PI3 kinase and mTOR inhibitors
12. 8129371 - Thienopyrimidine and pyrazolopyrimidine compounds and their use as mTOR kinase and PI3 kinase inhibitors
13. 8039469 - Triazine compounds as PI3 kinase and mTOR inhibitors
14. 7897639 - Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
15. 7795307 - Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents